We searched two electronic databases: Ovid MEDLINE (1946–Nov 25, 2014) and Ovid Embase (1947–Nov 25, 2014) for articles with the MeSH and Emtree terms “comorbidity” and “epilepsy”. We additionally searched for titles, abstracts, and keywords using the terms: comorbid*, epilepsy*, seizure*, convuls*, and epileptic*. The search was not limited by language of publication. Animal studies were excluded. Our initial search identified 3843 records after the removal of duplicates. The title and
ReviewComorbidities of epilepsy: current concepts and future perspectives
Introduction
Young adults have a median of two chronic health conditions, rising to six in people older than 65 years.1 These findings have led some researchers to refer to the co-occurrence of several medical conditions in the same individual as a normal state of affairs.2 A comorbid condition (or comorbidity) is one that occurs during the course of an index disease (eg, epilepsy). Comorbidities are generally defined in broad terms, including distinct clinical diseases and syndromes, and signs or symptoms of the index disease.1
Roughly 50% of adults with active epilepsy have at least one comorbid medical disorder.1, 2 Several large population-based studies report various conditions that are up to eight times more prevalent in people with epilepsy relative to the general population.3, 4 Appreciation of the relevance of these comorbidities is increasing because they affect epilepsy prognosis and quality of life. For example, migraine and psychiatric comorbidities are associated with poor seizure outcome, whereas depression has been linked with reduced quality of life.5, 6 Despite this growing appreciation, few data are available on the most effective methods to screen for comorbidities and the effect of interventions on prognosis.
Here, we describe ideas relevant to the investigation and conceptualisation of the comorbidities of epilepsy. We review the present state of knowledge of comorbidities associated with epilepsy and explore the ways in which research into comorbidities affords new opportunities for improvement in clinical care and scientific discovery.
Section snippets
Measuring comorbidity
A fundamental step in the study of the comorbidities of epilepsy is to understand the ways in which comorbidities are measured. An important measure of comorbidity burden is prevalence, which is generally understood to represent point prevalence—the proportion of individuals at risk with the condition in question at a single point in time.7 When discussing the comorbidities of epilepsy, the emphasis is on whether the prevalence of comorbid conditions in those with epilepsy is different from
Mechanisms of association
Straightforward measurement of associations between different diseases has been referred to as an “empirical statistical phenomenon that has no meaning in itself”.17 Measurement of associations is only the first step in a process in which an additional goal is to understand why specific conditions are associated, which in turn might change our understanding of epilepsy and its clinical care.
Several models have been generated to account for the relation between comorbid disorders.17, 18, 19 Such
The burden of comorbidity
Several large and comprehensive studies have examined the comorbidity burden in people with epilepsy, and we now describe this research and the relevance of such comorbidities in the context of the concepts underpinning comorbidity research discussed above. These large studies have used population-based cohorts and administrative databases in the UK,36 Canada,37, 38 and the USA,39, 40, 41, 42, 43 and have consistently shown a higher prevalence of several somatic and psychiatric conditions in
Screening and diagnosis
One of the more fundamental features of the comorbidities of epilepsy is their effects on the time of detection of the index disease since they might act as an iatrotropic stimulus.1 Regular neurological follow-up in individuals with a known brain neoplasm, for example, will enable earlier detection of a seizure disorder.
Understanding which comorbidities might develop in people with epilepsy is equally relevant. A report by the US Institute of Medicine emphasised the importance of the early
Future directions
Two major ways in which the investigation of comorbidities offers opportunities to further our understanding of epilepsy relate to the evolving notion of epilepsy as a spectrum, or part of a spectrum, and to their use as an important instrument in the study of genetics.
We have generally referred to epilepsy as a single, implicitly uniform entity, but epilepsy is, in fact, highly heterogeneous in terms of its cause, demographics, clinical manifestations, treatment, and prognosis. It is best
Conclusions
The comorbidities of epilepsy represent a substantial burden for people with epilepsy. The clinical and scientific community should continue to move forward, not only to focus on the description of the statistical relation between different conditions, but also to deconstruct the causal mechanisms for these comorbidities, while bearing in mind the risk of artifactual comorbidity. Screening instruments and guidelines should be developed to help translate the knowledge we have acquired into
Search strategy and selection criteria
References (97)
Pre-therapeutic classification of co-morbidity in chronic disease
J Chronic Dis
(1970)- et al.
Psychiatric comorbidities in epilepsy
Int Rev Neurobiol
(2008) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chronic Dis
(1987) Bias in analytic research
J Chronic Dis
(1979)- et al.
Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study
Lancet Neurol
(2005) - et al.
Epilepsy across the spectrum: promoting health and understanding. A summary of the Institute of Medicine report
Epilepsy Behav
(2012) - et al.
Comorbidity, health screening, and quality of life among persons with a history of epilepsy
Epilepsy Behav
(2009) - et al.
Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: prevalence and clinical characteristics
Epilepsy Res
(2015) - et al.
Late-onset seizures as a predictor of subsequent stroke
Lancet
(2004) - et al.
Value of routine screening for bone demineralization in an urban population of patients with epilepsy
Epilepsy Res
(2008)
Autoantibodies associated with diseases of the CNS: new developments and future challenges
Lancet Neurol
Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports
Biol Psychiatry
Causes and consequences of comorbidity: a review
J Clin Epidemiol
Predictors of pharmacoresistant epilepsy
Epilepsy Res
Academic problems in children with seizures: relationships with neuropsychological functioning and family variables during the 3 years after onset
Epilepsy Behav
Epilepsy and employment: literature review
Epilepsy Behav
Effect of comorbidities on medical care use and cost among refractory patients with partial seizure disorder
Epilepsy Behav
Epilepsy: new advances
Lancet
Sudden unexpected death in epilepsy: evidence-based analysis of incidence and risk factors
Epilepsy Res
Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study
Lancet
Prevalence of epilepsy in adults in northern Sweden
Epilepsia
The somatic comorbidity of epilepsy: a weighty but often unrecognized burden
Epilepsia
The impact of migraine on epilepsy: a prospective prognosis study
Cephalalgia
Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review
Epilepsia
Standards for epidemiologic studies and surveillance of epilepsy
Epilepsia
Approaches for estimating prevalence ratios
Occup Environ Med
Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio
BMC Med Res Methodol
Comorbidity measures for use with administrative data
Med Care
A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data
Med Care
Systematic review of comorbidity indices for administrative data
Med Care
Development of an epilepsy-specific risk adjustment comorbidity index
Epilepsia
The performance of three mortality risk-adjustment comorbidity indices in a community epilepsy cohort
Epilepsia
Comorbidity: concepts, claims and choices
Crim Behav Ment Health
Models of comorbidity for multifactorial disorders
Am J Hum Genet
The validity of the Neale and Kendler model-fitting approach in examining the etiology of comorbidity
Behav Genet
Cognitive impairment in tuberous sclerosis complex is a multifactorial condition
Neurology
The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification
Epilepsia
Validity in epidemiologic studies
Bias in research studies
Radiology
Bias
J Epidemiol Community Health
Causal diagrams
Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome
Brain
Causes of comorbidity: pleiotropy or causality? Shared genetic and environmental influences on migraine and neuroticism
Twin Res Hum Genet
Are cortical tubers epileptogenic? Evidence from electrocorticography
Epilepsia
Measures of effect and measures of association
Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele
Arch Neurol
Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study
Neurology
Cited by (445)
Epilepsy and psychiatric comorbidities: A bidirectional mendelian randomization study
2024, Journal of Affective DisordersEpilepsy and demyelination: Towards a bidirectional relationship
2024, Progress in NeurobiologySelf-management strategies for people with epilepsy: An overview of reviews
2024, Epilepsy and Behavior